1. Home
  2. PLSE vs ATUS Comparison

PLSE vs ATUS Comparison

Compare PLSE & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • ATUS
  • Stock Information
  • Founded
  • PLSE 2014
  • ATUS 2015
  • Country
  • PLSE United States
  • ATUS United States
  • Employees
  • PLSE 75
  • ATUS N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • ATUS Cable & Other Pay Television Services
  • Sector
  • PLSE Health Care
  • ATUS Telecommunications
  • Exchange
  • PLSE Nasdaq
  • ATUS Nasdaq
  • Market Cap
  • PLSE 1.3B
  • ATUS 1.1B
  • IPO Year
  • PLSE 2016
  • ATUS 2017
  • Fundamental
  • Price
  • PLSE $19.87
  • ATUS $2.70
  • Analyst Decision
  • PLSE Buy
  • ATUS Hold
  • Analyst Count
  • PLSE 1
  • ATUS 6
  • Target Price
  • PLSE $22.00
  • ATUS $2.88
  • AVG Volume (30 Days)
  • PLSE 254.2K
  • ATUS 4.3M
  • Earning Date
  • PLSE 10-29-2025
  • ATUS 11-06-2025
  • Dividend Yield
  • PLSE N/A
  • ATUS N/A
  • EPS Growth
  • PLSE N/A
  • ATUS N/A
  • EPS
  • PLSE N/A
  • ATUS N/A
  • Revenue
  • PLSE N/A
  • ATUS $8,762,212,000.00
  • Revenue This Year
  • PLSE N/A
  • ATUS N/A
  • Revenue Next Year
  • PLSE $700.00
  • ATUS N/A
  • P/E Ratio
  • PLSE N/A
  • ATUS N/A
  • Revenue Growth
  • PLSE N/A
  • ATUS N/A
  • 52 Week Low
  • PLSE $13.77
  • ATUS $1.95
  • 52 Week High
  • PLSE $25.00
  • ATUS $3.20
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 70.79
  • ATUS 56.69
  • Support Level
  • PLSE $17.10
  • ATUS $2.35
  • Resistance Level
  • PLSE $19.94
  • ATUS $2.63
  • Average True Range (ATR)
  • PLSE 0.83
  • ATUS 0.13
  • MACD
  • PLSE 0.20
  • ATUS 0.01
  • Stochastic Oscillator
  • PLSE 78.67
  • ATUS 56.25

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About ATUS Altice USA Inc.

Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.

Share on Social Networks: